fluorodeoxyglucose f18 has been researched along with Behavior Disorders in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.88) | 18.7374 |
| 1990's | 5 (14.71) | 18.2507 |
| 2000's | 12 (35.29) | 29.6817 |
| 2010's | 12 (35.29) | 24.3611 |
| 2020's | 3 (8.82) | 2.80 |
| Authors | Studies |
|---|---|
| Azuar, C; Baez, S; Boeve, B; Caramelli, P; Dallaire-Théroux, C; de Souza, LC; Devenney, E; Diehl-Schmid, J; Dols, A; Ducharme, S; Ellajosyula, R; Eratne, D; Galimberti, D; Gossink, F; Hodges, J; Hornberger, M; Huey, E; Ikeda, M; Kelso, W; Kumfor, F; Laforce, R; Landin-Romero, R; Le Ber, I; Lerner, A; Levy, R; Masellis, M; Mendez, M; Onyike, C; Pasquier, F; Perry, D; Piguet, O; Pijnenburg, Y; Pressman, P; Rosen, H; Santillo, A; Scarpini, E; Seelaar, H; Trieu, C; van den Stock, J; van Swieten, J; Vandenberghe, R; Vandenbulcke, M; Velakoulis, D; Vijverberg, E; Waldö, ML | 1 |
| Bombois, S; Boullet, A; Bruneteau, G; Delorme, C; Demeret, S; Doukhi, D; Fossati, P; Godefroy, N; Hesters, A; Kas, A; Le Guennec, L; Maatoug, R; Millet, B; Navarro, V; Paccoud, O; Pourcher, V; Shambrook, P | 1 |
| Benedet, AL; Chan, YH; Gauthier, S; Greenwood, CMT; Jiang, L; Kandiah, N; Mathotaarachchi, S; Ng, KP; Pascoal, TA; Rosa-Neto, P; Shin, M; Therriault, J | 1 |
| Aguirre-Benítez, EL; Albores-García, D; Avendaño, A; Ávila-Rodríguez, MA; Diaz, D; Garduño-Torres, DF; González-Ríos, J; Hernández-Falcón, J; Ibarra-Coronado, E; Jiménez-Estrada, I; Melo, AI; Mendoza-Ángeles, K; Mendoza-Garrido, ME; Parra, L; Porras, MG; Toriz, C | 1 |
| Camacho, V; Carceller-Sindreu, M; Carrió, I; Fernández-León, A; Gomez-Anson, B; Horta-Barba, A; Kulisevsky, J; Lopez-Mora, DA; Lozano-Martinez, GA; Martínez-Horta, S; Pagonabarraga, J; Perez-Perez, J; Sampedro, F | 1 |
| Baillés, E; Bargalló, N; Boget, T; Carreño, M; Donaire, A; Mané, A; Pintor, L; Ramos-Perdigués, S; Rumià, J; Setoain, X; Valdés, M | 1 |
| Carnero-Pardo, C; Gómez-Río, M; Górriz, JM; Martínez-Lozano, MD; Ramírez, J; Sánchez-Vañó, R; Segovia, F; Sopena-Novales, P; Triviño-Ibáñez, E | 1 |
| Backes, H; Endepols, H; Graf, R; Himmelreich, U; Mertgens, H; Mies, G; Neumaier, B | 1 |
| Cano, A; Domercq, M; Gómez-Vallejo, V; Higuchi, M; Llop, J; Martín, A; Matute, C; Muñoz, C; Padro, D; Szczupak, B | 1 |
| Damián, A; Engler, H; Schöll, M | 1 |
| Bikovsky, L; Desco, M; Hadar, R; Hamani, C; Klein, J; Pascau, J; Soto-Montenegro, ML; Weiner, I; Winter, C | 1 |
| Barkhof, F; Dols, A; Gossink, F; Kerssens, CJ; Krudop, WA; Möller, C; Peters, A; Pijnenburg, YA; Prins, ND; Scheltens, P; Stek, ML; van Berckel, BN; Vijverberg, EG; Wattjes, MP | 1 |
| Drzezga, A | 1 |
| Casquero-Veiga, M; Desco, M; Hadar, R; Pascau, J; Soto-Montenegro, ML; Winter, C | 1 |
| Arrowood, J; Clark, M; Colleton, M; Houle, S; Martin, K; Meyer, JH; Rusjan, P; Wilson, AA; Woodside, S | 1 |
| Honnorat, J; Ritzenthaler, T; Verret, JM | 1 |
| Akanuma, K; Ishii, H; Meguro, K; Meguro, M; Yamaguchi, S | 1 |
| Mann, JJ; Parsey, RV | 1 |
| Anchisi, D; Fazio, F; Franceschi, M; Matarrese, M; Moresco, RM; Pelati, O; Perani, D; Zuffi, M | 1 |
| Alia-Klein, N; Fowler, JS; Goldstein, RZ; Gur, RC; Hitzemann, R; Leskovjan, AC; Volkow, ND; Wang, GJ | 1 |
| Broderick, DF | 1 |
| Ances, B; Dalmau, J; Jiang, Z; Mason, W; Vitaliani, R; Zwerdling, T | 1 |
| Diehl-Schmid, J; Förstl, H; Kurz, A; Perneczky, R; Pohl, C | 1 |
| Kim, IJ; Kim, JI; Kim, SJ; Kim, YK; Ku, JG; Lee, HS; Lee, JS; Park, WW; Suh, KT | 1 |
| Bartlett, EJ; Brodie, JD; Dewey, SL; Fowler, JS; Rusinek, H; Simkowitz, P; Smith, G; Volkow, ND; Wolf, AP; Wolkin, A | 1 |
| Conley, RR; Tamminga, CA | 1 |
| Ito, H; Iwamoto, I; Kodama, K; Komatsu, N; Nawata, Y; Noda, S; Okada, S; Saito, Y; Sato, T; Takabayashi, K; Uchida, Y; Yamanouchi, N; Yoshikawa, K | 1 |
| Dobkin, CS; Grady, CL; Hinton, V; Horwitz, B; Mentis, MJ; Moore, CJ; Murphy, DG; Pietrini, P; Rapoport, SI; Schapiro, MB | 1 |
| Arning, C; Buell, U; Gouzoulis-Mayfrank, E; Kaiser, HJ; Sabri, O; Sass, H; Schreckenberger, M; Wagenknecht, G; Zeggel, T; Zimny, M | 1 |
| Alavi, A; Newberg, A; Reivich, M | 1 |
| Goldman, S; Michotte, A; Tugendhaft, P; Zegers de Beyl, D | 1 |
| Berecz, R; Degrell, I; Egerházi, A; Glaub, T; Lengyel, Z; Szakáll, S; Trón, L | 1 |
| London, ED | 1 |
| Mazziotta, JC; Phelps, ME | 1 |
8 review(s) available for fluorodeoxyglucose f18 and Behavior Disorders
| Article | Year |
|---|---|
Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders.
Topics: Delayed Diagnosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging; Male; Mental Disorders; Neuroimaging; Neurologic Examination; Neuropsychological Tests; Positron-Emission Tomography | 2020 |
Fluorodeoxyglucose PET in Neurology and Psychiatry.
Topics: Brain Diseases; Fluorodeoxyglucose F18; Humans; Mental Disorders; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Applications of positron emission tomography in psychiatry.
Topics: Brain; Dopamine; Fluorodeoxyglucose F18; Humans; Mental Disorders; Mood Disorders; Oxygen Radioisotopes; Psychiatry; Radiopharmaceuticals; Schizophrenia; Serotonin; Tomography, Emission-Computed | 2003 |
Neuroimaging in neuropsychiatry.
Topics: Brain; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mental Disorders; Neurotransmitter Agents; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2005 |
The application of neuroimaging techniques to drug development.
Topics: Antipsychotic Agents; Brain; Brain Chemistry; Carbon Radioisotopes; Cerebrovascular Circulation; Deoxyglucose; Diagnostic Imaging; Drug Industry; Drugs, Investigational; Fluorodeoxyglucose F18; Haloperidol; Humans; Ketamine; Magnetic Resonance Imaging; Mental Disorders; Neuropharmacology; Receptors, Dopamine; Spiperone; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1997 |
Determination of regional cerebral function with FDG-PET imaging in neuropsychiatric disorders.
Topics: Blood Glucose; Brain; Brain Diseases; Fluorodeoxyglucose F18; Humans; Mental Disorders; Radionuclide Imaging; Radiopharmaceuticals | 2002 |
[Use of positron emission tomography in psychiatry].
Topics: Alcoholism; Brain; Dementia; Fluorodeoxyglucose F18; Glucose; Humans; Mental Disorders; Mood Disorders; Obsessive-Compulsive Disorder; Radiopharmaceuticals; Schizophrenia; Tomography, Emission-Computed | 2002 |
Positron emission tomography: human brain function and biochemistry.
Topics: Acoustic Stimulation; Bipolar Disorder; Brain; Brain Diseases; Brain Neoplasms; Cerebrovascular Circulation; Cerebrovascular Disorders; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Kinetics; Mental Disorders; Neurotransmitter Agents; Oxygen Consumption; Pharmaceutical Preparations; Pharmacology; Photic Stimulation; Tomography, Emission-Computed; Visual Cortex | 1985 |
1 trial(s) available for fluorodeoxyglucose f18 and Behavior Disorders
| Article | Year |
|---|---|
"Ecstasy"-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology. An 18-FDG PET study.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Cerebral Cortex; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Disorders; Middle Aged; Psychological Tests; Radionuclide Imaging; Radiopharmaceuticals | 1999 |
25 other study(ies) available for fluorodeoxyglucose f18 and Behavior Disorders
| Article | Year |
|---|---|
COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings.
Topics: Aged; Brain Diseases; Cerebellar Diseases; Cognition Disorders; COVID-19; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Immunotherapy; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Myoclonus; Neuropsychological Tests; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Status Epilepticus; Treatment Outcome | 2020 |
Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease.
Topics: Adult; Age of Onset; Aged; Alzheimer Disease; Disease Progression; Factor Analysis, Statistical; Female; Fluorodeoxyglucose F18; Heterozygote; Humans; Longitudinal Studies; Male; Mental Disorders; Middle Aged; Mutation; Nervous System Diseases; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Disruption of behavior and brain metabolism in artificially reared rats.
Topics: Age Factors; Animals; Animals, Newborn; Brain; Disease Models, Animal; Exploratory Behavior; Female; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Male; Mental Disorders; Neuroglia; Neurons; Physical Stimulation; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Social Isolation; Stress, Psychological; Touch | 2017 |
Structural and metabolic brain correlates of apathy in Huntington's disease.
Topics: Aged; Apathy; Atrophy; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Huntington Disease; Imaging, Three-Dimensional; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Tomography Scanners, X-Ray Computed | 2018 |
Psychiatric Symptoms in Refractory Epilepsy During the First Year After Surgery.
Topics: Adult; Drug Resistant Epilepsy; Electroencephalography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Neurosurgical Procedures; Positron-Emission Tomography; Postoperative Complications; Prospective Studies; Psychiatric Status Rating Scales; Retrospective Studies | 2018 |
Usefulness of Dual-Point Amyloid PET Scans in Appropriate Use Criteria: A Multicenter Study.
Topics: Amyloid; Aniline Compounds; Brain; Cognitive Dysfunction; Dementia; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Mental Disorders; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Stilbenes | 2018 |
Longitudinal assessment of infarct progression, brain metabolism and behavior following anterior cerebral artery occlusion in rats.
Topics: Animals; Anterior Cerebral Artery; Antipyrine; Autoradiography; Brain; Brain Infarction; Cerebrovascular Circulation; Disease Models, Animal; Disease Progression; Endothelin-1; Fluorodeoxyglucose F18; Infarction, Middle Cerebral Artery; Isotopes; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Disorders; Positron-Emission Tomography; Rats; Time Factors | 2015 |
In vivo PET imaging of the α4β2 nicotinic acetylcholine receptor as a marker for brain inflammation after cerebral ischemia.
Topics: Amides; Animals; Brain; CD11b Antigen; Cell Count; Dihydro-beta-Erythroidine; Disease Models, Animal; Encephalitis; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Infarction, Middle Cerebral Artery; Isoquinolines; Magnetic Resonance Imaging; Male; Mental Disorders; Positron-Emission Tomography; Protein Binding; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Time Factors | 2015 |
Deep brain stimulation improves behavior and modulates neural circuits in a rodent model of schizophrenia.
Topics: Acoustic Stimulation; Animals; Animals, Newborn; Brain; Deep Brain Stimulation; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Interferon Inducers; Male; Mental Disorders; Nucleus Accumbens; Poly I-C; Positron-Emission Tomography; Prefrontal Cortex; Prepulse Inhibition; Rats; Rats, Wistar; Reflex, Startle; Schizophrenia | 2016 |
Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes.
Topics: Age of Onset; Aged; Atrophy; Brain; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Neuroimaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
2016 SNMMI Highlights Lecture: Neurosciences.
Topics: Fluorodeoxyglucose F18; Humans; Mental Disorders; Movement Disorders; Neurosciences; Nuclear Medicine; Positron-Emission Tomography; Protein Aggregation, Pathological; Societies, Medical | 2016 |
Response to Deep Brain Stimulation in Three Brain Targets with Implications in Mental Disorders: A PET Study in Rats.
Topics: Animals; Brain; Deep Brain Stimulation; Fluorodeoxyglucose F18; Glucose; Male; Mental Disorders; Positron-Emission Tomography; Rats; Rats, Wistar; Treatment Outcome | 2016 |
Serotonin2A receptor binding potential in people with aggressive and violent behaviour.
Topics: Adult; Aggression; Aging; Brain; Brain Chemistry; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Mental Disorders; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals; Receptor, Serotonin, 5-HT2A; Violence | 2008 |
[Paraneoplastic chorea and behavioral disorders in a patient with anti-CV2/CRMP5 antibodies and two different tumors].
Topics: Aged, 80 and over; Autoantibodies; Chorea; Dyslipidemias; Electrodiagnosis; Fluorodeoxyglucose F18; Humans; Hydrolases; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Mental Disorders; Microtubule-Associated Proteins; Myocardial Infarction; Nerve Tissue Proteins; Obsessive-Compulsive Disorder; Paraneoplastic Polyneuropathy; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2010 |
Assessment of mental deterioration with the Cognitive Abilities Screening Instrument (CASI) and glucose hypometabolism in Alzheimer's disease: the Osaki-Tajiri Project.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Brain; Brain Mapping; Cognition Disorders; Community-Based Participatory Research; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose Metabolism Disorders; Humans; Male; Mental Disorders; Mental Status Schedule; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Ultrasonography | 2009 |
Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration.
Topics: Aged; Brain; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Disorders; Neuropsychological Tests; Positron-Emission Tomography; Receptors, Serotonin | 2005 |
Anger and depression in cocaine addiction: association with the orbitofrontal cortex.
Topics: Adult; Anger; Chronic Disease; Cocaine-Related Disorders; Cognition Disorders; Depression; Disruptive, Impulse Control, and Conduct Disorders; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Inhibition, Psychological; Mental Disorders; MMPI; Personality Disorders; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals; Severity of Illness Index | 2005 |
Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma.
Topics: Adolescent; Adult; Animals; Antibodies, Neoplasm; Blotting, Western; Brain; Cells, Cultured; Encephalitis; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Hippocampus; Humans; Hypoventilation; Immunoglobulin G; Immunohistochemistry; Magnetic Resonance Imaging; Mental Disorders; Neurons; Ovarian Neoplasms; Positron-Emission Tomography; Rats; Teratoma; Time Factors | 2005 |
Behavioral disturbances in the course of frontotemporal dementia.
Topics: Age of Onset; Aged; Dementia; Feeding and Eating Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Radiopharmaceuticals | 2006 |
Cerebral glucose metabolic abnormality in patients with congenital scoliosis.
Topics: Adolescent; Brain; Child; Female; Fluorodeoxyglucose F18; Glucose; Humans; Intelligence; Male; Mental Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Scoliosis | 2008 |
Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects.
Topics: Adult; Brain; Cerebellum; Cerebral Cortex; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Haloperidol; Humans; Limbic System; Male; Mental Disorders; Putamen; Thalamus; Tomography, Emission-Computed | 1994 |
Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms.
Topics: Adolescent; Adult; Attention; Brain; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Mental Disorders; Mental Status Schedule; Neuropsychological Tests; Organ Specificity; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Premutation female carriers of fragile X syndrome: a pilot study on brain anatomy and metabolism.
Topics: Adult; Brain; Case-Control Studies; Confounding Factors, Epidemiologic; Female; Fluorodeoxyglucose F18; Fragile X Syndrome; Heterozygote; Humans; Magnetic Resonance Imaging; Mental Disorders; Mutation; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Frontotemporal dementia: a clinical-pathological study.
Topics: Adult; Aphasia; Atrophy; Cell Count; Dementia; Fatal Outcome; Female; Fluorodeoxyglucose F18; Frontal Lobe; Gliosis; Humans; Mental Disorders; Neurons; Personality Disorders; tau Proteins; Temporal Lobe; Tomography, Emission-Computed; Ubiquitin | 2001 |
The effects of drug abuse on glucose metabolism.
Topics: Brain; Deoxyglucose; Electroencephalography; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Disorders; Morphine; Narcotics; Placebos; Substance-Related Disorders; Tomography, Emission-Computed | 1989 |